Sprayable Hydrogel Protects Heart from Post-Surgical Adhesions
|
By HospiMedica International staff writers Posted on 29 Jun 2021 |

Image: A spray-on gel isolates the heart from surrounding tissue to minimize adhesions (Photo courtesy of Getty Images)
A new study describes how a novel hydrogel binds to the heart muscle to form a soft, elastic barrier that protects it from adhesions following surgery.
Developed at the University of California, San Diego (UCSD; USA), the hydrogel barrier is comprised of aldehyde (ALD), aminooxy (AO), and oxime crosslinked poly(ethylene glycol) (PEG), functionalized with a catechol (CAT) group, that are mixed together to form the final gel (ALD-AO-CAT). The gel has favorable mechanical properties, degradation kinetics, minimal swelling, and superior tissue retention. The material is also cytocompatible, resists cell adhesion, and reduces the severity of adhesions. It can be easily removed from tissue and dissolves after four to six weeks.
The researchers also designed a device to safely and accurately spray the hydrogel inside the surgical field during open heart surgery. The spraying device houses the hydrogel's two main components in two different chambers; each is made of PEG with different reactive groups that crosslink together to form the hydrogel. One of the solutions also includes the catechol-modified PEG to ensure it stays on the heart. The two mix as they exit the device, forming the hydrogel. The researchers described the process as akin to using two cans of spray paint, for example blue and yellow, to create a third color, green. The study was published on June 18, 2021, in Nature Communications.
“We demonstrated here that the ALD–AO–CAT hydrogel possesses mechanical characteristics and degradation kinetics that are well-suited to the conditions within the chest cavity. The material also demonstrated a lower degree of swelling that surpasses the behavior of existing products,” said senior author Professor Karen Christman, PhD, and colleagues. “Our work is an engineering solution driven by a medical problem, and now it's poised to significantly improve cardiac surgery, both for adults and children.”
Depressed fibrinolytic activity resulting from surgical trauma to the epicardium during open-heart procedures can lead to fibrous adhesion formations between the epicardium and other tissues in the chest cavity. For children born with congenital heart defects, who will experience multiple surgeries over their lifetime, and adults receiving valve replacements, mechanical circulatory support, and/or coronary artery bypass grafting, this problem is particularly relevant, as these adhesions impede heart function and severely complicate resternotomy by obstructing visibility and increasing the risk of mortality and morbidity during dissection.
Related Links:
University of California, San Diego
Developed at the University of California, San Diego (UCSD; USA), the hydrogel barrier is comprised of aldehyde (ALD), aminooxy (AO), and oxime crosslinked poly(ethylene glycol) (PEG), functionalized with a catechol (CAT) group, that are mixed together to form the final gel (ALD-AO-CAT). The gel has favorable mechanical properties, degradation kinetics, minimal swelling, and superior tissue retention. The material is also cytocompatible, resists cell adhesion, and reduces the severity of adhesions. It can be easily removed from tissue and dissolves after four to six weeks.
The researchers also designed a device to safely and accurately spray the hydrogel inside the surgical field during open heart surgery. The spraying device houses the hydrogel's two main components in two different chambers; each is made of PEG with different reactive groups that crosslink together to form the hydrogel. One of the solutions also includes the catechol-modified PEG to ensure it stays on the heart. The two mix as they exit the device, forming the hydrogel. The researchers described the process as akin to using two cans of spray paint, for example blue and yellow, to create a third color, green. The study was published on June 18, 2021, in Nature Communications.
“We demonstrated here that the ALD–AO–CAT hydrogel possesses mechanical characteristics and degradation kinetics that are well-suited to the conditions within the chest cavity. The material also demonstrated a lower degree of swelling that surpasses the behavior of existing products,” said senior author Professor Karen Christman, PhD, and colleagues. “Our work is an engineering solution driven by a medical problem, and now it's poised to significantly improve cardiac surgery, both for adults and children.”
Depressed fibrinolytic activity resulting from surgical trauma to the epicardium during open-heart procedures can lead to fibrous adhesion formations between the epicardium and other tissues in the chest cavity. For children born with congenital heart defects, who will experience multiple surgeries over their lifetime, and adults receiving valve replacements, mechanical circulatory support, and/or coronary artery bypass grafting, this problem is particularly relevant, as these adhesions impede heart function and severely complicate resternotomy by obstructing visibility and increasing the risk of mortality and morbidity during dissection.
Related Links:
University of California, San Diego
Latest Surgical Techniques News
- Robotic Assistant Delivers Ultra-Precision Injections with Rapid Setup Times
- Minimally Invasive Endoscopic Surgery Improves Severe Stroke Outcomes
- Novel Glue Prevents Complications After Breast Cancer Surgery
- Breakthrough Brain Implant Enables Safer and More Precise Drug Delivery
- Bioadhesive Sponge Stops Uncontrolled Internal Bleeding During Surgery
- Revolutionary Nano Bone Material to Accelerate Surgery and Healing
- Superior Orthopedic Implants Combat Infections and Quicken Healing After Surgery
- Laser-Based Technique Eliminates Pancreatic Tumors While Protecting Healthy Tissue
- Surgical Treatment of Severe Carotid Artery Stenosis Benefits Blood-Brain Barrier
- Revolutionary Reusable Duodenoscope Introduces 68-Minute Sterilization
- World's First Transcatheter Smart Implant Monitors and Treats Congestion in Heart Failure
- Hybrid Endoscope Marks Breakthrough in Surgical Visualization
- Robot-Assisted Bronchoscope Diagnoses Tiniest and Hardest to Reach Lung Tumors
- Diamond-Titanium Device Paves Way for Smart Implants that Warn of Disease Progression
- 3D Printable Bio-Active Glass Could Serve as Bone Replacement Material
- Spider-Inspired Magnetic Soft Robots to Perform Minimally Invasive GI Tract Procedures
Channels
Critical Care
view channel
Ingestible Capsule Monitors Intestinal Inflammation
Acute mesenteric ischemia—a life-threatening condition caused by blocked blood flow to the intestines—remains difficult to diagnose early because its symptoms often mimic common digestive problems.... Read more
Wireless Implantable Sensor Enables Continuous Endoleak Monitoring
Endovascular aneurysm repair (EVAR) is a life-saving, minimally invasive treatment for abdominal aortic aneurysms—balloon-like bulges in the aorta that can rupture with fatal consequences.... Read more
Wearable Patch for Early Skin Cancer Detection to Reduce Unnecessary Biopsies
Skin cancer remains one of the most dangerous and common cancers worldwide, with early detection crucial for improving survival rates. Traditional diagnostic methods—visual inspections, imaging, and biopsies—can... Read morePatient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read moreFirst-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel
Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies
Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
B. Braun Acquires Digital Microsurgery Company True Digital Surgery
The high-end microsurgery market in neurosurgery, spine, and ENT is undergoing a significant transformation. Traditional analog microscopes are giving way to digital exoscopes, which provide improved visualization,... Read more
CMEF 2025 to Promote Holistic and High-Quality Development of Medical and Health Industry
The 92nd China International Medical Equipment Fair (CMEF 2025) Autumn Exhibition is scheduled to be held from September 26 to 29 at the China Import and Export Fair Complex (Canton Fair Complex) in Guangzhou.... Read more







